ArticleScientific reports2026
Association between preoperative anemia and revision risk after total shoulder arthroplasty: a multi-institutional cohort study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective cohort study explored the association between preoperative anemia and the risk of revision surgery following total shoulder arthroplasty (TSA). Using the TriNetX database, we analyzed patients aged ≥ 50 years who underwent primary TSA between 2010 and 2024. Patients were classified as anemic (hemoglobin 8-12 g/dL) or non-anemic (≥ 12 g/dL), and propensity score matching was applied in a 1:1 ratio. After matching, 10,838 patients were included (5,419 per group). At three-year follow-up, patients with preoperative anemia demonstrated significantly higher risks of TSA revision (hazard ratio [HR]: 1.58, p < 0.001), periprosthetic joint infection (HR: 1.98, p < 0.001), mortality (HR: 2.65, p < 0.001), pneumonia (HR: 1.66, p < 0.001), and emergency department visits (HR: 1.18, p < 0.001). One-year results showed consistent trends, with mortality risk being notably higher (HR: 3.29 vs. 2.65). Sensitivity analyses restricted to academic medical centers, patients with minimum three-year survival, and individuals with mild anemia consistently reinforced these findings. A validation cohort from the pre-COVID-19 era confirmed the associations. These findings suggest that preoperative anemia may represent an opportunity for risk stratification and optimization following TSA. Whether preoperative correction of anemia can reduce these risks warrants investigation in prospective interventional studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.